Journal article icon

Journal article

Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: A cost-utility analysis comparing meropenem with piperacillin/tazobactam

Abstract:

Background: Treating patients admitted to critical care with severe pneumonia requires timely intervention with an effective antibiotic. This reduces the risk of dying of pneumonia and minimises complications associated with a prolonged stay in critical care. Objective: To compare the cost-effectiveness of meropenem 1 g/8 h with piperacillin/tazobactam 4.5 g/8 h for treating pneumonia in UK critical care. Methods: A Markov model was built to estimate lifetime costs and quality-adjusted life y...

Expand abstract

Actions


Access Document


Publisher copy:
10.1007/s10198-011-0296-0

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Population Health
Role:
Author
Journal:
European Journal of Health Economics More from this journal
Volume:
13
Issue:
2
Pages:
181-192
Publication date:
2012-04-01
DOI:
EISSN:
1618-7601
ISSN:
1618-7598
Language:
English
Keywords:
Pubs id:
pubs:321566
UUID:
uuid:cc5b346e-5c9e-4e1f-8a13-2593a4e5b072
Local pid:
pubs:321566
Source identifiers:
321566
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP